Results 101 to 110 of about 21,464 (246)
Gene therapy in renal diseases
Gene therapy in renal diseases. Kidney-targeted gene therapy could be an ideal treatment for renal diseases since the therapeutic molecule is limited in the kidney and the systemic effect may be minimized.
Isaka, Yoshitaka +3 more
core +1 more source
Objective To systematically evaluate management strategies and associated outcomes of iatrogenic ureteric injuries, focusing on clinical success, renal unit loss, and the need for subsequent endoscopic or reconstructive procedures. Patients and Methods A pre‐registered protocol (CRD420251184018) guided a comprehensive search of PubMed and EMBASE ...
Pietro Scilipoti +17 more
wiley +1 more source
Biallelic SLC20A1 loss‐of‐function variant causes a previously unrecognized multisystem developmental disorder. We report the first homozygous case presenting with tetralogy of Fallot, renal agenesis, polydactyly, and growth impairment. Transcriptome analysis of patient‐derived fibroblasts suggests significant dysregulation of pathways critical for ...
Eugénie Koumakis +9 more
wiley +1 more source
ABSTRACT Liver fibrosis is a shared pathological phenotype of chronic liver diseases of diverse etiologies, including viral hepatitis, alcohol‐associated liver disease and metabolic dysfunction–associated steatohepatitis (MASH), as well as cholestatic liver diseases such as primary biliary cholangitis and primary sclerosing cholangitis, and may ...
Kiminori Kimura, Michinori Kohara
wiley +1 more source
Background Ureteral stricture is a common condition characterized by fibrotic narrowing of the ureter, often resulting in obstruction and impaired renal function.
Jie Zheng +5 more
doaj +1 more source
Abstract This literature‐based systematic review and associated guidelines provide evidence‐based paradigms for the management of locoregionally recurrent rectal cancer (LRRC). This multispecialty committee included gastrointestinal radiation and medical oncology, gastroenterology, radiology, and colorectal surgery.
Eric D. Miller +18 more
wiley +1 more source
10-Year Experience with Reinforced Ureteral Stents for Malignant Ureteral Obstruction
Benoît Vogt,1 Laure-Hélène Blanchet2 1Department of Urology, Polyclinique de Blois, La Chaussée Saint-Victor, 41260, France; 2Department of Public Health, Hôpital Saint-Antoine (AP-HP), Paris, 75012, FranceCorrespondence: Benoît VogtDepartment of Urology,
Vogt B, Blanchet LH
doaj
Minimmally invasive resolution of a left ureteral stenosis after Schistosoma haematobium infection
Genitourinary schistosomiasis is an acquired cause of urinary tract diseases, especially hematuria. Schistosoma haematobium can infect travelers after a single exposure. Bladder is the most frequent organ involved within the urinary tract, although upper
Andres González +5 more
core +1 more source
Compartment‐Specific Immune Remodeling of Renal Aging With C1q‐Associated Podocyte Activation
Aging repatterns the renal immune response in a compartment‐specific manner, distinct from chronic kidney disease (CKD) adaptation. Glomerular aging features C1q‐associated podocyte activation and macrophage engagement, whereas tubulointerstitial aging is marked by B‐cell aggregation and tertiary lymphoid structure expansion.
Ju‐Young Moon +10 more
wiley +1 more source
Diagnostic Values of Serum Procalcitonin in Kidney Diseases
Many clinical studies have confirmed Procalcitonin (PCT) as a specific inflammatory marker in sepsis and bacterial infections. It is believed that PCT level is increased in various noninfectious conditions such as acute pancreatitis, major surgery ...
Ghafari, Alireza +2 more
core +1 more source

